Kohjin Bio Co., Ltd. Logo

Kohjin Bio Co., Ltd.

Develops and sells culture media, biological materials, and diagnostics for research.

177A | T

Overview

Corporate Details

ISIN(s):
JP3283630006
LEI:
Country:
Japan
Address:
坂戸市千代田5−1−3

Description

Kohjin Bio Co., Ltd. is a biotechnology company that develops, manufactures, and sells a range of products for life science research and clinical applications. The company's core offerings include tissue culture media, with a focus on serum-free formulations for regenerative medicine and immunotherapy research, as well as media for microbial testing and diagnostics. It also supplies animal-derived biological materials such as blood, serum, and plasma. Additionally, Kohjin Bio provides contract cell processing services for cancer immune cell therapy in collaboration with medical institutions and offers products like in vitro diagnostic drugs and immunochromatographic assay kits.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-13 07:30
確認書
Japanese 8.9 KB
2025-11-13 07:30
半期報告書-第45期(2025/04/01-2026/03/31)
Japanese 215.4 KB
2025-06-27 08:30
臨時報告書
Japanese 23.8 KB
2025-06-24 09:09
内部統制報告書-第44期(2024/04/01-2025/03/31)
Japanese 25.0 KB
2025-06-24 09:08
確認書
Japanese 9.0 KB
2025-06-24 09:06
有価証券報告書-第44期(2024/04/01-2025/03/31)
Japanese 1.8 MB
2024-11-14 07:30
確認書
Japanese 8.9 KB
2024-11-14 07:30
半期報告書-第44期(2024/04/01-2025/03/31)
Japanese 200.4 KB
2024-07-04 02:15
臨時報告書
Japanese 27.7 KB
2024-06-28 08:09
確認書
Japanese 9.0 KB
2024-06-28 08:00
有価証券報告書-第43期(2023/04/01-2024/03/31)
Japanese 1.7 MB
2024-04-25 05:44
臨時報告書
Japanese 21.2 KB
2024-04-16 08:01
訂正有価証券届出書(新規公開時)
Japanese 1.8 MB
2024-04-08 03:00
訂正有価証券届出書(新規公開時)
Japanese 1.8 MB
2024-03-22 07:00
有価証券届出書(新規公開時)
Japanese 3.5 MB

Automate Your Workflow. Get a real-time feed of all Kohjin Bio Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kohjin Bio Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kohjin Bio Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.